DHT causes hair loss, but the mechanism is more complex than most providers were taught. Dihydrotestosterone (DHT) can miniaturize hair follicles in genetically sensitive individuals, but it can also promote hair growth under different conditions. The difference between hair loss and hair health often comes down to genetics, local tissue concentration, and the metabolic environment surrounding the follicle.
This matters for clinicians because patients are arriving with questions about DHT, hair thinning, and whether their hormone therapy is causing the problem. If you are prescribing testosterone, optimizing thyroid, or managing hormones in any capacity, understanding the real relationship between DHT and hair loss will change how you counsel patients and how you treat.
What Is DHT and What Does It Do?
Dihydrotestosterone (DHT) is the most potent androgen the body naturally produces. It is a direct metabolite of testosterone, converted by an enzyme called 5-alpha reductase.
About 5 to 10 percent of circulating testosterone is converted to DHT. That conversion happens in multiple tissues, including the skin, prostate, liver, and hair follicles.
DHT is essential for normal development. During puberty, it drives the growth of facial hair, body hair, and the maturation of the reproductive system. In adult life, it continues to support muscle maintenance, bone density, libido, and neurological function.
The problem is not DHT itself. The problem is what happens when genetically susceptible follicles are exposed to certain concentrations of DHT over time.
How DHT Causes Hair Loss: The Mechanism
DHT causes hair loss through a process called follicular miniaturization.
Here is how it works. DHT binds to androgen receptors on the dermal papilla of the hair follicle. In individuals with a genetic predisposition, this binding shortens the anagen (growth) phase and progressively shrinks the follicle. Over successive growth cycles, the follicle produces thinner, shorter, lighter hairs until it eventually produces only microscopic vellus hair or stops producing visible hair altogether.
This process is gradual. It does not happen overnight. And it does not happen uniformly across the scalp. DHT-sensitive follicles cluster at the temples, crown, and frontal hairline. The follicles at the sides and back of the head are typically resistant, which is why those areas are preserved even in advanced androgenetic alopecia.
The clinical term for this pattern is androgenetic alopecia. The “androgenetic” label is important: it requires both the androgen (DHT) and the genetic susceptibility. One without the other does not produce the pattern.
Why DHT Does Not Always Cause Hair Loss
This is where the story gets more nuanced than what most resources teach.
Research has shown that testosterone and even DHT can have positive anabolic effects on hair follicles under certain conditions. In studies of women, testosterone levels above 300 ng/dL did not increase hair loss. In some cases, they actually showed a thickening effect on follicles.
Animal studies have demonstrated that topical DHT can promote hair growth and increase follicle thickness at specific concentrations. The outcome depends entirely on the dose:
- At concentrations of 10^-5 to 10^-6 mol/L, DHT inhibited follicle growth.
- At 10^-7 mol/L, DHT promoted growth.
- At 10^-8 mol/L, DHT had minimal effect.
This concentration-dependent response explains why some individuals with high DHT have full heads of hair, while others with lower DHT levels experience significant thinning. Serum DHT levels do not predict hair loss. What matters is the local concentration of DHT at the follicle and how that individual’s androgen receptors respond to it.
The Role of 5-Alpha Reductase
5-alpha reductase is the enzyme that converts testosterone into DHT. There are two primary isoforms:
Type 1 is found predominantly in the skin, including the scalp. Type 2 is concentrated in the prostate, liver, and hair follicles of the beard and scalp.
Both isoforms contribute to local DHT production. This is why systemic DHT levels measured in blood do not tell the full story. A patient can have normal serum DHT and still have elevated local conversion at the follicle.
5-alpha reductase activity is influenced by genetics, but it is also modulated by the hormonal and metabolic environment. Chronic stress, inflammation, and hormonal imbalances can all alter enzyme activity and shift the balance toward greater local DHT production.
This is where the conventional approach of simply blocking DHT with finasteride falls short. It addresses one variable in a multivariable problem.
Genetics and Androgen Receptor Sensitivity
Genetic susceptibility is the gatekeeper.
The androgen receptor (AR) gene, located on the X chromosome, determines how sensitive a follicle is to DHT. Variations in this gene increase androgen receptivity in scalp follicles, making the individual more prone to miniaturization even at normal DHT levels.
This is why hair loss runs in families but does not follow a simple pattern. A patient may have elevated testosterone and DHT and never lose hair. Another patient may have modest androgen levels and experience significant thinning. The difference is receptor density and sensitivity at the follicle.
For clinicians, this means that chasing DHT levels in bloodwork is not a productive diagnostic strategy for hair loss. The genetics and local tissue environment matter far more than a serum number.
The Hormones That Actually Drive Hair Loss
DHT is one variable. But hair loss is a metabolic event, not just an androgenic one.
The hormones and factors that contribute to hair loss extend well beyond DHT:
Thyroid. Hypothyroidism is one of the most common and most overlooked causes of hair thinning. Thyroid hormone directly supports mitochondrial function in the hair follicle. When thyroid is insufficient, the follicle does not have the cellular energy to sustain a normal growth cycle. Diffuse thinning across the entire scalp, not just the androgen-sensitive areas, is a hallmark of thyroid-related hair loss. If thyroid is not addressed, optimizing other hormones will not fully resolve the problem.
Progesterone. Progesterone is a natural 5-alpha reductase inhibitor. It competes with testosterone for the enzyme, reducing local DHT conversion. When progesterone is deficient, there is less enzymatic competition and more testosterone gets converted to DHT at the tissue level. This is one of the reasons perimenopausal women, who lose progesterone before they lose estradiol, often notice hair changes early.
Progesterone also converts via 5-alpha reductase to allopregnanolone, a neurosteroid that modulates GABA receptors. This matters because chronic stress and poor sleep, both downstream of low allopregnanolone, create a cortisol-dominant environment that further damages follicle health.
Estradiol. In women, adequate estradiol supports the anagen phase and maintains follicle health. Low estradiol, as seen in menopause, accelerates follicle cycling and contributes to thinning. This is separate from the DHT mechanism and often coexists with it.
Cortisol. Chronic cortisol elevation is catabolic. It breaks down connective tissue, impairs circulation, suppresses anabolic hormones (testosterone, progesterone), and shifts the metabolic environment toward inflammation and glycolysis. Follicles in a high-cortisol environment are energy-depleted and structurally compromised. You cannot grow healthy hair in a body that is metabolically stressed.
Inflammation and the microbiome. Disruptions in the gut microbiome, environmental toxins, and oxidative stress all contribute to systemic and local inflammation that damages follicle health. Endotoxin (lipopolysaccharide) from gram-negative bacteria can trigger inflammatory cascades that suppress protective hormones and accelerate tissue breakdown.
Why DHT Blockers Alone Rarely Solve the Problem
Finasteride and dutasteride are 5-alpha reductase inhibitors. They reduce DHT production systemically. And they do slow hair loss in many patients.
But they do not address the metabolic environment.
If the follicle is also dealing with thyroid insufficiency, progesterone deficiency, chronic cortisol, poor nutrition, or systemic inflammation, blocking DHT addresses one input while leaving the others untouched. This is why many patients on finasteride experience a plateau or partial response. The drug is working on the androgen signal, but the follicle is still energy-depleted from other causes.
There are also real concerns about long-term side effects. Finasteride has been associated with persistent sexual side effects, mood changes, and neurological symptoms in a subset of users. These effects make sense when you understand that DHT is not just a scalp hormone. It supports neurological function, libido, and tissue integrity throughout the body.
The clinical question is not “should we block DHT?” It is “what is the full picture of why this follicle is failing, and what does it need to recover?”
A Metabolic Approach to Hair Loss
Supporting healthy metabolism and optimizing hormone balance is one of the most effective and sustainable ways to improve hair health.
For your patients, this means:
Optimize thyroid first. Thyroid is often the first domino. If TSH is “normal” but the patient is symptomatic, look deeper. Free T3, free T4, and reverse T3 can reveal a picture that TSH alone misses. Optimal thyroid function restores the cellular energy the follicle needs to maintain its growth cycle.
Restore progesterone. In women, progesterone replacement not only competes with 5-alpha reductase but also supports sleep, stress resilience, and metabolic balance. In men, progesterone has a role in specific clinical situations. Progesterone is far more than uterine protection. It is a metabolic and neurological hormone.
Assess and optimize testosterone. Testosterone supports muscle mass, dopaminergic function, and metabolic health. Deficiency mimics mood disorders and accelerates metabolic decline. In the context of hair, the goal is not to suppress testosterone but to ensure the metabolic environment handles it well.
Address cortisol upstream. Rather than testing cortisol directly, treat what drives chronic elevation: restore thyroid, progesterone, and testosterone. Hormone replacement therapy is the backbone of cortisol management because it restores the anti-stress hormones that buffer the stress response.
Support nutrition. Vitamin D3, zinc, selenium, magnesium, and adequate protein are foundational. These cofactors support mitochondrial function, thyroid conversion, and the structural integrity of the follicle itself.
Reduce environmental and oxidative stress. Seed oils (PUFAs), ultra-processed foods, and environmental endocrine disruptors contribute to the inflammatory and oxidative load that damages follicles over time. Reducing these exposures is part of the metabolic picture.
Inside the HRTU Master Course, there is a full module dedicated to metabolic foundations, including these concepts and a pro-metabolic hair growth serum recipe designed to support follicle health from the outside in.
What Providers Get Wrong About DHT and Hair Loss
The most common mistake is treating hair loss as a single-variable problem.
A patient presents with thinning hair. The reflex is to check DHT, prescribe finasteride, and call it addressed. But if that patient also has suboptimal thyroid, low progesterone, elevated cortisol, poor gut health, and a diet high in seed oils, the finasteride is working against a metabolic headwind.
The second mistake is avoiding testosterone replacement out of fear that it will cause hair loss. Testosterone does convert to DHT. But the clinical evidence shows that optimized testosterone, in the context of adequate thyroid and progesterone, does not automatically accelerate hair loss. The genetic susceptibility and the overall metabolic environment are what determine the outcome.
The third mistake is measuring serum DHT and making clinical decisions based on that number. Blood DHT does not reflect local tissue concentration. A normal serum level does not rule out elevated follicular DHT, and an elevated serum level does not guarantee hair loss.
Frequently Asked Questions
Does DHT directly cause hair loss? DHT contributes to hair loss by binding to androgen receptors on genetically susceptible hair follicles, causing them to miniaturize over time. However, DHT alone does not cause hair loss. Genetic receptor sensitivity and the metabolic environment both play essential roles.
Can testosterone replacement therapy cause hair loss? Testosterone converts to DHT via 5-alpha reductase, so there is a theoretical pathway. In practice, hair loss from TRT depends on the individual’s genetic susceptibility and overall hormonal balance. Adequate thyroid and progesterone can help buffer the androgenic signal.
Does progesterone help with hair loss? Progesterone is a natural 5-alpha reductase inhibitor. It competes with testosterone for the enzyme, reducing local DHT conversion at the tissue level. Progesterone deficiency, which is common in perimenopause, can contribute to increased local DHT and hair thinning.
Is serum DHT testing useful for diagnosing hair loss? Serum DHT levels do not correlate well with hair loss. What matters is the local concentration of DHT at the follicle and the sensitivity of the androgen receptors. Blood tests for DHT are not a reliable predictor of who will or will not lose hair.
What is the best approach to treating DHT-related hair loss? The most effective approach addresses the full metabolic picture: thyroid optimization, progesterone restoration, cortisol management, nutritional support, and reducing inflammatory and oxidative stress. DHT blockers may play a role, but they are most effective as one part of a comprehensive strategy.
Can hair loss be reversed with hormone optimization? In many cases, yes. When the underlying metabolic and hormonal imbalances are corrected, follicles that have not yet been permanently destroyed can recover. Hair growth is often one of the first visible signs that the body is returning to metabolic balance.
What role does thyroid play in hair loss? Thyroid hormone directly supports mitochondrial function in the hair follicle. Hypothyroidism causes diffuse thinning across the scalp, distinct from the pattern seen in androgenetic alopecia. If thyroid is not optimized, other interventions for hair loss will have limited effect.
For a complete overview of hormone replacement and bioidentical hormone therapy, or to learn how these principles are taught inside the HRTU Master Course, explore our HRT training for nurse practitioners and providers.
